{"id":11567,"date":"2020-05-26T17:12:25","date_gmt":"2020-05-26T21:12:25","guid":{"rendered":"https:\/\/www.bumc.bu.edu\/im-residency\/?page_id=11567"},"modified":"2020-05-26T17:12:25","modified_gmt":"2020-05-26T21:12:25","slug":"assessing-the-use-of-procalcitonin-in-lower-respiratory-tract-infections-in-the-medical-intensive-care-unit","status":"publish","type":"page","link":"https:\/\/www.bumc.bu.edu\/im-residency\/assessing-the-use-of-procalcitonin-in-lower-respiratory-tract-infections-in-the-medical-intensive-care-unit\/","title":{"rendered":"Assessing the use of Procalcitonin in Lower Respiratory Tract Infections in the Medical Intensive Care Unit"},"content":{"rendered":"<p><img loading=\"lazy\" src=\"\/im-residency\/files\/2020\/05\/DJ-Wallman-Poster.jpg\" alt=\"\" width=\"8400\" height=\"5250\" class=\"aligncenter size-full wp-image-11566\" srcset=\"https:\/\/www.bumc.bu.edu\/im-residency\/files\/2020\/05\/DJ-Wallman-Poster.jpg 8400w, https:\/\/www.bumc.bu.edu\/im-residency\/files\/2020\/05\/DJ-Wallman-Poster-480x300.jpg 480w, https:\/\/www.bumc.bu.edu\/im-residency\/files\/2020\/05\/DJ-Wallman-Poster-768x480.jpg 768w, https:\/\/www.bumc.bu.edu\/im-residency\/files\/2020\/05\/DJ-Wallman-Poster-1024x640.jpg 1024w\" sizes=\"(max-width: 8400px) 100vw, 8400px\" \/><\/p>\n<h3>DJ Wallman, MD<\/h3>\n<p><strong>Authors:<\/strong>\u00a0Daniel Wallman, MD,\u00a0Ryan Knodle, MD,\u00a0Joan Savage, MD,\u00a0Swetha Ramachadran, MD.,\u00a0Kim Ackerbaum, PharmD,\u00a0Megan Feeney, PharmD.,\u00a0Shyam Patel, PharmD,\u00a0Allan Walkey, MD,\u00a0Tamar Barlam, MD<\/p>\n<p><strong>Background:\u00a0<\/strong>Routine use of procalcitonin has not yet fully been taken up in everyday clinical practice; however, multiple studies have found the biomarker to be a useful clinical tool for aiding in antimicrobial stewardship interventions when used in the appropriate context. The IDSA has recommended that the procalcitonin should be measured in a serial fashion that best meets the institution\u2019s needs in order to enhance antibiotic stewardship.<\/p>\n<p><strong>Objective:<\/strong> To identify and analyze baseline procalcitonin ordering practices on patients with a lower respiratory tract infection admitted to the BMC MICU.<\/p>\n<p><strong>Methods:<\/strong> All patients admitted to the BMC MICU with a suspected or confirmed diagnosis of a lower respiratory tract infection in whom a procalcitonin was ordered and were started on antibiotics from January 2019 to February 2019 were observed for the following metrics: 1) if and when a follow up procalcitonin was ordered, 2) the value of each procalcitonin obtained thereafter.<\/p>\n<p><strong>Results:<\/strong> 29 patients met inclusion criteria. 6 (20%) did not have a follow up PCT level and 5 of those had initial levels greater than 0.5 (a positive result). Of those who did have a follow up value obtained, 17 (73%) were measured within 24 hours of the initial level, 6 (26%) within 24-48 hours of the initial level and 2 (8%) were measured after 48 hours of the initial measurement.<span>\u00a0 <\/span><\/p>\n<p><strong>Conclusion:<\/strong> The current ordering practices for procalcitonin in the BMC MICU is not serialized and ordering practices are variable. Further study is undergoing in order to rectify this.<span>\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DJ Wallman, MD Authors:\u00a0Daniel Wallman, MD,\u00a0Ryan Knodle, MD,\u00a0Joan Savage, MD,\u00a0Swetha Ramachadran, MD.,\u00a0Kim Ackerbaum, PharmD,\u00a0Megan Feeney, PharmD.,\u00a0Shyam Patel, PharmD,\u00a0Allan Walkey, MD,\u00a0Tamar Barlam, MD Background:\u00a0Routine use of procalcitonin has not yet fully been taken up in everyday clinical practice; however, multiple studies have found the biomarker to be a useful clinical tool for aiding in antimicrobial stewardship [&hellip;]<\/p>\n","protected":false},"author":15816,"featured_media":0,"parent":0,"menu_order":102,"comment_status":"open","ping_status":"closed","template":"page-templates\/no-sidebars.php","meta":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/im-residency\/wp-json\/wp\/v2\/pages\/11567"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/im-residency\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/im-residency\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/im-residency\/wp-json\/wp\/v2\/users\/15816"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/im-residency\/wp-json\/wp\/v2\/comments?post=11567"}],"version-history":[{"count":1,"href":"https:\/\/www.bumc.bu.edu\/im-residency\/wp-json\/wp\/v2\/pages\/11567\/revisions"}],"predecessor-version":[{"id":11568,"href":"https:\/\/www.bumc.bu.edu\/im-residency\/wp-json\/wp\/v2\/pages\/11567\/revisions\/11568"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/im-residency\/wp-json\/wp\/v2\/media?parent=11567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}